(株)カイオム・バイオサイエンスの貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4583/E26096Chiome Bioscience Inc.
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2024/05/17日証協無担保4,400株+83.33%0株0%22,000株+168.29%
2024/05/17日証協有担保2,619,420株+260.01%131,200株+148.02%240,000株+64.16%
2024/05/10日証協無担保2,400株+71.43%0株0%8,200株-75.81%
2024/05/10日証協有担保727,592株-66.09%52,900株-61.16%146,196株-71.59%
2024/05/02日証協無担保1,400株-82.5%0株0%33,900株+143.88%
2024/05/02日証協有担保2,145,900株+389.1%136,200株+39.84%514,600株+779.66%
2024/04/26日証協無担保8,000株-48.39%0株0%13,900株-82.34%
2024/04/26日証協有担保438,744株-64.29%97,400株+51.48%58,500株-87.17%
2024/04/19日証協無担保15,500株+28.1%0株0%78,700株+664.08%
2024/04/19日証協有担保1,228,548株-37.43%64,300株-70.76%456,042株+209.81%
2024/04/12日証協無担保12,100株+57.14%0株0%10,300株-87.36%
2024/04/12日証協有担保1,963,400株-43.89%219,900株-52.59%147,200株-45.2%
2024/04/05日証協無担保7,700株+11.59%0株0%81,500株-2.28%
2024/04/05日証協有担保3,499,120株-4.16%463,800株+20.31%268,600株-65.93%
2024/03/29日証協無担保6,900株0%0株0%83,400株+118.32%
2024/03/29日証協有担保3,650,872株+128.77%385,500株+1206.78%788,400株+317.81%
2024/03/22日証協無担保0株-100%0株0%38,200株-62.03%
2024/03/22日証協有担保1,595,900株-35.3%29,500株-91.49%188,700株-67.47%
2024/03/15日証協無担保6,800株+300%0株0%100,600株+65.19%
2024/03/15日証協有担保2,466,600株+82.24%346,500株+6316.67%580,000株+151.95%
2024/03/08日証協無担保1,700株+325%0株0%60,900株-2.09%
2024/03/08日証協有担保1,353,500株-37.03%5,400株-58.14%230,200株-34.33%
2024/03/01日証協無担保400株0%0株0%62,200株-29.48%
2024/03/01日証協有担保2,149,400株+115.48%12,900株0%350,542株-31.43%
2024/02/22日証協無担保0株-100%0株0%88,200株-86.21%
2024/02/22日証協有担保997,500株+16.95%0株-100%511,242株+75.9%
2024/02/16日証協無担保6,400株0%0株0%639,800株0%
2024/02/16日証協有担保852,900株0%382,100株0%290,642株0%
2024/02/09日証協無担保7,100株0%0株0%62,400株0%
2024/02/09日証協有担保1,380,500株0%47,300株0%262,000株0%
2024/02/02日証協無担保21,100株0%0株0%27,000株0%
2024/02/02日証協有担保1,176,872株0%58,500株0%391,000株0%
2024/01/26日証協無担保2,700株0%0株0%39,501株0%
2024/01/26日証協有担保2,294,000株0%0株0%265,400株0%
2024/01/19日証協無担保4,300株0%0株0%74,700株0%
2024/01/19日証協有担保3,780,972株0%81,100株0%708,300株0%
2024/01/12日証協無担保400株0%0株0%29,300株0%
2024/01/12日証協有担保784,900株0%43,000株0%62,800株0%

※株式分割は考慮していませんのでご注意ください。

Page Top